SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001445305-13-001744
Filing Date
2013-07-30
Accepted
2013-07-30 16:12:14
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2013063010q.htm 10-Q 1840040
2 EXHIBIT a20130630ex311.htm EX-31.1 10243
3 EXHIBIT a20130630ex312.htm EX-31.2 11225
4 EXHIBIT a20130630ex321.htm EX-32.1 6756
5 EXHIBIT a20130630ex322.htm EX-32.2 8234
  Complete submission text file 0001445305-13-001744.txt   16024446

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT celg-20130630.xml EX-101.INS 2151033
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celg-20130630.xsd EX-101.SCH 50860
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT celg-20130630_cal.xml EX-101.CAL 93051
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celg-20130630_def.xml EX-101.DEF 232596
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celg-20130630_lab.xml EX-101.LAB 728078
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celg-20130630_pre.xml EX-101.PRE 403023
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34912 | Film No.: 13996056
SIC: 2834 Pharmaceutical Preparations